Table 1:

Patient characteristics at time of first appearance of low-ADC lesion

Patient CharacteristicsNo.
Patients with low-ADC lesions27
Age (median) (range)53 (34–74)
Sex
    Men20
    Women7
Chemotherapy at time of low-ADC lesion
    Contains bevacizumab15
        Bevacizumab only7
        Bevacizumab and irinotecan1
        Bevacizumab and temozolomide5
        Bevacizumab and carboplatin1
        Bevacizumab and lomustine1
    Does not contain bevacizumab6
        Temozolomide only6
    None6